The application deals with IgA proteases, extracellular bacterial proteolytic enzymes that cleave and inactivate human mucosal and salivary IgAl antibody proteins. IgA proteases of various human pathogenic bacteria are all post-proline cleaving and have very high, possibly unique specificity for human IgA heavy chain as substrate. Bacteria making this enzyme include oral streptococci e.g. S. sanguis that colonizes human dental enamel to form plaque, a complex, adherent microbial aggregate (continaing abundant protease activity) that leads to caries. We will test the general hypothesis that during their extracellular secretion the IgA proteases of dividing bacteria interact with mucosal or salivary IgA anti-protease antibodies in a way that fosters, and regulates, bacterial aggregation during the complex process of colonization of host mucosal tissues and the proteinaceous pellicle on dental enamel. We will test the biological role of these proteases by growing recombinant streptococcal strains in human saliva bathing hydroxyapatite similar to that on natural teeth. We have recently cloned and sequenced the entire S. sanguis iqa gene that encodes IgA protease, and it will be analyzed using gene fusions and related recombinant techniques. This is to establish the role of a long tandem repeat that has been found in the enzyme protein structure and to localize its human IgA-binding, zinc-binding and antigenic domains, and to understand the genetic and biochemical relationship of streptococcal to other IgA proteases of Gram negative pathogens. We also will design, synthesize, and characterize by NMR spectroscopy peptide boronic acid-type and other potent inhibitors of the streptococcal and oral Bacteroides enzymes similar to those we recently developed for the serine-type IgA proteases of Neisserea and Hemophilus pathogens. These will be used to probe the role of the enzymes in colonization of dental enamel, with a view to drugs that may limit this process. Such compounds will also serve as guides to synthesis of effective substrates for the metallo-enzyme-type IgA proteases like those of S. sanguis, a longstanding and unsolved problem that has blocked study of their role in pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE009677-04
Application #
2130691
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1991-02-01
Project End
1996-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Serruto, Davide; Spadafina, Tiziana; Ciucchi, Laura et al. (2010) Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A 107:3770-5
Hendrixson, D R; Qiu, J; Shewry, S C et al. (2003) Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol Microbiol 47:607-17
Chintalacharuvu, Koteswara R; Chuang, Philip D; Dragoman, Ashley et al. (2003) Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infect Immun 71:2563-70
Plaut, A G; Qiu, J; St Geme 3rd, J W (2000) Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 19 Suppl 1:S148-52
Smith, D J; King, W F; Gilbert, J V et al. (1998) Structural integrity of infant salivary immunoglobulin A (IgA) in IgA1 protease-rich environments. Oral Microbiol Immunol 13:89-96
Qiu, J; Hendrixson, D R; Baker, E N et al. (1998) Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci U S A 95:12641-6
Wani, J H; Gilbert, J V; Plaut, A G et al. (1996) Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun 64:3967-74
Stenberg, L; Qiu, J; Lindahl, G et al. (1996) Lack of interference between IgA-binding proteins and IgA proteases of human pathogenic bacteria. J Med Microbiol 44:65-9
Kane, A V; Plaut, A G (1996) Unique susceptibility of Helicobacter pylori to simethicone emulsifiers in alimentary therapeutic agents. Antimicrob Agents Chemother 40:500-2
Plaut, A G; Wright, A (1995) Immunoglobulin A-metallo-type specific prolyl endopeptidases. Methods Enzymol 248:634-42

Showing the most recent 10 out of 14 publications